Why Are Monoclonal Antibodies the First Prime Targets for Animal-Free Testing at FDA?
New government roadmap reflects growing confidence in AI, organ chips, and other alternatives that outperform animals in safety testing for targeted therapies You can listen to an AI-generated reading of this story here: On April